Predictive value of cytomegalovirus DNA detection by polymerase chain reaction in blood and bronchoalveolar lavage in lung transplant patients

Transplantation

Volumn 63, Issue 10, 1997, Pages 1430-1435

  Stéphan, François ^a   Fajac, Anne ^a   Grenet, Dominique ^b   Honderlick, Patrick ^b   Ricci, Sylvie ^a   Frachon, Irène ^b   Friard, Sylvie ^b   Caubarrere, Isabelle ^b   Bernaudin, Jean François ^a   Stern, Marc ^b  

^a HÔPITAL TENON   (France)

^b FOCH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; THYMOGLOBULINES; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ARTICLE; BLOOD CULTURE; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DNA DETERMINATION; FEMALE; GRAFT REJECTION; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; TRANSBRONCHIAL BIOPSY; VIRUS CULTURE;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOMEGALOVIRUS; DNA, VIRAL; DRUG EVALUATION; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 0343765842     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705270-00011     Document Type: Article

References (39)

1. Ettinger NA, Bailey TC, Trulock EP, et al. Cytomegalovirus infection and pneumonitis: impact after isolated lung transplantation. Am Rev Respir Dis 1993; 147: 1017.
2. Duncan SR, Grgurich WF, Iacono AT, et al. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med 1994; 150: 146.
3. Bailey TC, Trulock EP, Ettinger NA, Storch GA, Cooper JD, Powderly WG. Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants. J Infect Dis 1992; 165: 548.
4. Maurer JR, Snell G, de Hoyos A, Kesten S, Winton T. Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens. Transplant Proc 1993; 25: 1434.
5. Gould FK, Freeman R, Taylor CE, Ashcroft T, Dark JH, Corris PA. Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: a review of experience in one center. J Heart Lung Transplant 1993; 12: 965.
6. Duncan SR, Paradis IL, Dauber JH, Yousem SA, Hardesty RL, Griffith BP. Ganciclovir prophylaxis for cytomegalovirus infections in pulmonary allograft recipients. Am Rev Respir Dis 1992; 146: 1213.
7. Rubin RH. Preemptive therapy in immunocompromised hosts. N Engl J Med 1991; 324: 1057.
8. Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogenic bone marrow transplants. N Engl J Med 1991; 324: 1005.
9. Jiwa NM, Van Gemert GW, Raap AK, et al. Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction. Transplantation 1989; 48: 72.
10. Gerna G, Zipeto D, Parea M, et al. Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia. J Infect Dis 1991; 164: 488.
11. Cathomas G, Morris P, Pelke K, Cunningham I, Emanuel D. Rapid diagnosis of cytomegalovirus pneumonia in marrow transplant recipients by bronchoalveolar lavage using the polymerase chain reaction, virus culture, and the direct immunostaining of alveolar cells. Blood 1993; 81: 1909.
12. Eriksson B-M, Brytting M, Zweygberg-Wirgart B, Hillerdal G, Olding-Stenkvist E, Linde A. Diagnosis of cytomegalovirus in bronchoalveolar lavage by polymerase chain reaction, in comparison with virus isolation and detection of viral antigen. Scand J Infect Dis 1993; 25: 421.
13. Xu W, Sundqvist V-A, Brytting M, Linde A. Diagnosis of cytomegalovirus infections using polymerase chain reaction, virus isolation and serology. Scand J Infect Dis 1993; 25: 311.
14. Schmidt CA, Oettle H, Neuhaus P, et al. Demonstration of cytomegalovirus by polymerase chain reaction after liver transplantation. Transplantation 1993; 56: 872.
15. Zipeto D, Revello GR, Silini E, et al. Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients. J Clin Microbiol 1992; 30: 527.
16. Einsele H, Steidle M, Vallbracht T, Saal JG, Ehninger G, Muller CA. Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood 1991; 77: 104.
17. Einsele H, Ehninger G, Steidle M, et al. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet 1991; 338: 1170.
18. Vlieger AM, Boland GJ, De Weger NM, Willemze R, De Gast GC, Falkenburg JHF. Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients. Bone Marrow Transplant 1992; 9: 247.
19. Prösch S, Kimel V, Dawydowa I, Krüger DH. Monitoring of patients for cytomegalovirus after organ transplantation by centrifugation culture and PCR. J Med Virol 1992; 38: 246.
20. Buffone GJ, Frost A, Samo T, Demmler GJ, Cagle PT, Lawrence EC. The diagnosis of CMV pneumonitis in lung and heart/lung transplant patients by PCR compared with traditional laboratory criteria. Transplantation 1993; 56: 342.
21. Manez R, Kusne S, Rinaldo C, et al. Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J Infect Dis 1996; 173: 1072.
22. Boland GJ, De Weger RA, Tilanus MGJ, Ververs C, Bosboom-Kalsbeek K, De Gast GC. Detection of cytomegalovirus (CMV) in granulocytes by polymerase chain reaction compared with the CMV antigen test. J Clin Microbiol 1992; 30: 1763.
23. Delgado R, Lumbreras C, Alba C, et al. Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol 1992; 30: 1876.
24. Van Den Berg AP, Van Son WJ, Haagsma EB, et al. Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients. Transplantation 1993; 55: 847.
25. Bitsch A, Kirchner H, Dennin R, et al. The long persistence of CMV DNA in the blood of renal transplant patients after recovery from CMV infection. Transplantation 1993; 56: 108.
26. Weber B, Nestler U, Ernst W, et al. Low correlation of human cytomegalovirus DNA amplification by the polymerase chain reaction with cytomegalovirus disease in organ transplant recipients. J Med Virol 1994; 43: 187.
27. Patel R, Smith TF, Espy M, et al. A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J Infect Dis 1995; 171: 1010.
28. Paya CV, Wold AD, Smith TF. Detection of cytomegalovirus infections in specimens other than urine by shell vial assay and conventional tube cell cultures. J Clin Microbiol 1987; 25: 755.
29. Ljungman P, Griffiths P. Definitions of cytomegalovirus infections and disease. In: Michelson S, Plotkin SA, eds. Multidisciplinary approach to understanding of cytomegalovirus disease. Paris: Elsevier Science Publishers, 1993: 233.
30. Higuchi R. Simple and rapid preparation of samples for PCR. In Erlich HA, ed. PCR technology: principles and applications for DNA amplification. New York: Stockton Press, 1989: 31.
31. Fajac A, Vidaud M, Lebargy F, et al. Evaluation of human cytomegalovirus latency in alveolar macrophages. Am J Respir Crit Care Med 1994; 149: 495.
32. Hennighausen L, Fleckhenstein B. Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene. EMBO J 1986; 5: 1367.
33. Drouet E, Michelson S, Denoyel G, Colimon R. Polymerase chain reaction detection of human cytomegalovirus in over 2000 blood specimens correlated with virus isolation and related to urinary virus excretion. J Virol Methods 1993; 45: 259.
34. Armitage P, Berry G, eds. Statistical methods in medical research. Oxford: Blackwell Scientific Publications, 1994.
35. Griner PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretation of diagnostic tests and procedures: principles and applications. Ann Intern Med 1981; 94: 553.
36. Von Laer D, Serr A, Meyer-König U, Kirste G, Hufert FT, Haller O. Human cytomegalovirus immediate early and late transcripts are expressed in all major leukocyte populations in vivo. J Infect Dis 1995; 172: 365.
37. Pillay D, Ali AA, Liu SF, Kops E, Sweny P, Griffiths PD. The prognostic significance of positive CMV cultures during surveillance of renal transplant recipients. Transplantation 1993; 56: 103.
38. Meyers JD, Ljungman P, Fisher LD. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis 1990; 162: 373.
39. Badley AD, Patel R, Portela DF, et al. Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipients. J Infect Dis 1996; 173: 446.